Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
about
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineMechanisms and models of endoplasmic reticulum stress in chondrodysplasiaHLA engineering of human pluripotent stem cellsPatient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor.Impaired neural differentiation potency by retinoic acid receptor-α pathway defect in induced pluripotent stem cellsEffect of Intra-Medullar and Intra-Venous Infusions of Mesenchymal Stem Cells on Cell Engraftment by In-Vivo Cell Tracking and Osteoinductivity in Rabbit Long Bones: A Pilot StudyThe Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone DisordersNew lessons learned from disease modeling with induced pluripotent stem cells.Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor.Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.Find and replace: editing human genome in pluripotent stem cellsThe promise and challenges of stem cell-based therapies for skeletal diseases: stem cell applications in skeletal medicine: potential, cell sources and characteristics, and challenges of clinical translationMesenchymal stem cells in tissue repairGene delivery to bone.Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors.State of the art in stem cell research: human embryonic stem cells, induced pluripotent stem cells, and transdifferentiation.Gene delivery techniques for adult stem cell-based regenerative therapy.Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.Stem Cells in Skeletal Tissue Engineering: Technologies and Models.Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicitySilent IL2RG Gene Editing in Human Pluripotent Stem Cells.Lack of genotoxicity due to foamy virus vector integration in human iPSCs.Which form of collagen is suitable for nerve cell culture?Evolution of iPSC disease models.Low osteogenic yield in human pluripotent stem cells associates with differential neural crest promoter methylation.New frontiers for dominant osteogenesis imperfecta treatment: gene/cellular therapy approachesTreatment options for osteogenesis imperfecta
P2860
Q26751506-FD51EC7F-F09D-4869-88B0-9A2B6630B308Q26995280-9FF72F6C-BED1-4161-9EB1-AA2892C30073Q30540471-20D55525-EE96-480C-9E24-7E3F22210DDCQ33788974-51657B9F-5BE0-4F2C-8D72-A53D43E7B506Q33862395-1B6C912D-7AF6-41D0-8702-AE31C9B2FCDDQ34579393-B27F190E-2FAF-42B1-8AE8-35CA57C39CB8Q34698972-A53CDBBA-AD69-4F92-887F-29B522795428Q34990691-8E3CF910-1804-4150-8AA5-C5A874B33346Q36374130-DFB3A208-C6E8-484B-9986-C97A7A82C003Q36810424-B9E47654-B4D3-4956-B6A1-EBEC5DCB1717Q36867065-8862184D-9A6A-40EC-88AA-3D68FC9205DBQ36922762-B56BEC9D-E5C3-49F2-94E0-C58A787461F3Q36965820-C556E925-C2C3-4470-BF7C-C0644AF08603Q37142817-95CA785C-6F11-460E-B238-B3670F91D956Q38000390-CDBC3585-7827-4C08-B47A-BCA52C159DEEQ38062875-D23366DC-58F9-419A-9483-FB0D08EE98B0Q38134206-0600998E-19DF-45EF-910B-A680A07AB33AQ38148755-DB0048F2-36A1-4D24-830B-1244F8322B32Q38155214-2FEEA561-FB29-4543-8D5F-D9B8E2FD3179Q38557791-B1A68B28-9654-4359-AFCF-5F00AB646AB8Q38595986-C292E4F1-CC8D-4FC8-BF16-09C5A888ED95Q38843031-849AF941-D43E-4C8F-8296-F992BEC9B17DQ38919592-3611D8D4-B702-46FA-85C2-82572382E78DQ39198486-05F23E87-CE5A-47B3-93C6-049E8C12B76EQ41819123-5A43D43A-FB91-406B-9C9C-92E290134FDEQ42566526-313A8BCC-2E94-4955-B6A0-E3579A0E5EA0Q46744518-922FAB05-371C-4BDF-87BC-D9FB5E5D80A3Q58270335-2C955C26-0786-4AD9-AE09-3A996DD2DE29Q58752199-97C5754D-BB39-40E2-B2D5-FEED2F41C3A8
P2860
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
@en
type
label
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
@en
prefLabel
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
@en
P2093
P2860
P356
P1433
P1476
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.
@en
P2093
David R Deyle
Gaoying Ren
Iram F Khan
Jordan Kho
Pei-Rong Wang
Ulrike Schwarze
P2860
P304
P356
10.1038/MT.2011.209
P577
2011-10-25T00:00:00Z